Dr. David Berger was invited to give an oral presentation at the FDA Vaccines and Related Biological Products Advisory Committee meeting (February 26, 2021) to discuss the Emergency Use Authorization (EUA) of the Johnson & Johsnon/Jansenn Biotech, Inc. COVID-19 Vaccine (Docket No. FDA-2021-N-0173). Dr. Berger will address continued COVID-19 vaccine hesitancy and safety concerns related to women of childbearing age. Below are the slides of Dr. Berger’s presentation to the committee.
DOWNLOAD DR. BERGER’S SLIDE PRESENTATION HERE:
